Microgen, headquartered in the UK, is a leading global provider of software solutions and IT services to a wide range of markets.
Numerix analytics are embedded into Microgen’s Independent Valuation and Risk (IVR) solution, a module within the company’s Aptitude offering that addresses processing, data management, valuation and risk compliance for OTC derivatives. IVR empowers banks, insurance companies, hedge funds, asset managers and corporate treasuries with an in-house environment for managing all aspects of the derivatives valuation process. It interfaces with most front and back office systems, supports STP and exception-based processing, extracts positions directly from source systems, prices OTC positions and provides end user reports.
Numerix technology powers the platform’s exotic OTC derivatives pricing and risk calculation engine, giving users access to the most comprehensive collection of models and methods across asset classes. Users may choose specific Numerix pricing modules, with the turn-key ability to structure and price any OTC derivative or structured product, including bespoke transactions.